James Brugarolas | sciencenewsnet.in

Breaking News

Insurance challenges limit psychologists’ capacity to address ongoing mental health needs

$10.8 million grant supports cutting-edge leukemia research

Healthy eating habits to carry you through the holidays

Dr. Edward J. Feser Named 34th President of Saint Louis University

ما هي تنبؤاتك الصحية؟ خبير يشرح التفسير العلمي وراء التوجيهات الشخصية المتعلقة بالعافية

NYU Tandon researchers create microchips capable of detecting and diagnosing diseases

Governor Hochul Celebrates the Opening Of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center in Buffalo

Across southeastern US, weedy rice steals herbicide resistance from crop rice

Threat of abrupt mortality events keeps endangered monkey population at risk, despite decades of growth

Controller with Integrated Machine Learning Tweaks Fusion Plasmas in Real Time

17 Dec, 2024

FDA Approval Of Belzutifan Culminates 25-Year Journey at UTSW From Gene Discovery to A First-In-Class Drug

August 23, 2021 sarah JonasResearch Results

DALLAS – Aug. 23, 2021 – A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.